Related Experiment Video
Updated: May 23, 2026
05:02
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
Interleukin-34-Induced Arg1+ Macrophages Play a Key Role in Breast Cancer Brain Metastasis
Xiaoqing Cheng1, Khooshbu K Patel2, Brandon Zhou1
1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Cancer Research Communications
|May 21, 2026
Summary
Breast cancer brain metastases rely on interleukin-34 (IL34) to grow. Blocking IL34 or its receptor CSF1R significantly inhibited tumor development in a new mouse model, suggesting a potential therapeutic strategy.
Area of Science:
- Oncology
- Immunology
- Neuroscience
Background:
- Brain metastases are common in Stage IV breast cancer, particularly in the cerebellum for HER2-positive cases.
- Understanding the mechanisms driving brain metastasis is crucial for developing effective treatments.
Purpose of the Study:
- To develop a syngeneic mouse model for studying breast cancer brain metastases.
- To investigate the role of interleukin-34 (IL34) in the establishment and growth of brain metastases.
Main Methods:
- Developed a mouse model by stereotactically injecting murine breast cancer organoids into the cerebellum.
- Utilized spatial transcriptomics to analyze gene expression in brain metastases.
- Measured IL34 expression in human brain metastasis samples from two independent datasets.
- Tested the efficacy of IL34 deficiency and CSF1R-blocking antibodies in vivo.
Main Results:
- Breast cancer cells were found to produce IL34, which recruits ARG1+ macrophages at the tumor edge.
- IL34 was widely expressed in both HER2-positive and HER2-negative human breast cancer brain metastases.
- IL34-deficient breast cancer cells failed to form tumors in the cerebellum.
- Treatment with a CSF1R-blocking antibody caused significant tumor shrinkage.
Conclusions:
- IL34 is essential for the initiation and growth of breast cancer brain metastases.
- Targeting the IL34/CSF1R axis represents a promising therapeutic strategy for brain metastases.
- The developed mouse model is valuable for preclinical studies of brain metastases.
